📰 Interim Efficacy News
Interim Efficacy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Efficacy. Real-time updates on events, politics, business and more.
April 18, 2023
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class oncology therapeutics, announced positive interim...
April 13, 2023
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class oncology therapeutics, announced that it will present...
December 11, 2022
RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet responses in Patients with...
October 12, 2022
First presentation of RSV Older Adult vaccine candidates pivotal phase III efficacy and safety data New data showing Shingrix... | October 12, 2022